# IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage

> **NCT07054801** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Daniel Raper, MBBS** · enrollment: 25 (estimated)

## Conditions studied

- Headaches Associated With Subarachnoid Hemorrhage (SAH)

## Interventions

- **DRUG:** Lidocaine hydrochloride
- **DRUG:** Methylprednisolone sodium succinate

## Key facts

- **NCT ID:** NCT07054801
- **Lead sponsor:** Daniel Raper, MBBS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07054801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07054801, "IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07054801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*